|
|
Happy Marriage = Happy Sleep
|
|
|
|
| |
Participation In Research & Clinical Trials
Helping expand & improve healthcare — & quality of life — for patients in need.
 What is a Clinical Study or Trial?
A clinical research study is also called a clinical trial. Each study tests the safety, effectiveness, and side effects of an investigational medicine(s) or an investigational device on a group of volunteers. Clinical research studies are an important step in making new investigational medications available for future use.
Go back to the top
Should I volunteer
Every day, research uncovers new information about diseases and their treatment. By taking part in a clinical research study, you are an important link in a long chain of research and testing of new investigational medicines for future use.
Go back to the top
Devoted to the advancement of pulmonary & COPD care.
At Midwest Chest Consultants, we are dedicated to providing the highest standard of care for patients with pulmonary disorders and diseases. For this reason, we’ve made a point of getting and staying involved in research studies that can improve the standard of care.
Today, in addition to our pulmonology practice, we run a full-time clinical trials operation. We have dedicated full-time professionals devoted to this part of our practice and to ensuring the most complete, thorough and accurate information and patient care. Since 1991, we have conducted nearly 70 different clinical trials, and we’re today in demand by pharmaceutical companies who demand top-quality investigative data. We are presently conducting several studies on COPD, and we have more planned for the future.
Go back to the top
How can patients benefit from participation in clinical trials?
With decades of experience as pulmonologists and investigators, we know that patients — particularly those with COPD — are interested in receiving closer care. In other words, they desire more hands-on time with the specialist, which is a key motivator for patients to participate in clinical trials. This is particularly the case for patients who are still struggling with their illness despite treatment.
Patients considering participation in COPD studies also benefit simply from the screening process. Regardless of whether they are chosen for the study, they receive a “snapshot” of their lung function (spirometry) at no cost. Other motivators include greater frequency of specialty tests and exams, zero-cost medications and care, priority visits, reimbursement for time and expenses and the potential for effective relief that has otherwise been elusive.
Go back to the top
Who is eligible?
Today, most pharmaceutical companies that are researching new treatments desire a particular type of COPD patient. For starters, because age is an important factor in the incidence of COPD, patients must be age 40 or older in order to be eligible. A personal history of smoking is also a key eligibility factor, and the ideal candidate is a COPD patient who has a history of one or more packs per day for 10 or more years.
If you or someone you know is interested in a COPD clinical trial, please call us for more information.
Go back to the top
COPD facts & stats:
- COPD is the fourth-leading cause of death in America.
- In 2004, 11.4 million U.S. adults were estimated to have COPD. However, close to 24 million adults have evidence of impaired lung function, indicating that COPD is underdiagnosed.
- Smoking is the primary risk factor for COPD. Approximately 80% to 90% of COPD cases are caused by smoking.
- Female smokers are nearly 13 times as likely to die from COPD as women who have never smoked. Male smokers are nearly 12 times as likely to die from COPD as men who have never smoked.
- The number of women dying from COPD is greater than the number of men.
- In 2004, an estimated 9 million Americans reported a physician diagnosis of chronic bronchitis. Chronic bronchitis affects people of all ages but is higher in those over 45 years old. Of the estimated 3.6 million Americans ever diagnosed with emphysema, 91% were 45 or older.
Source: American Lung Association
Go back to the top
Participation In Research & Clinical Trials
Helping expand & improve healthcare — & quality of life — for patients in need.
What is a Clinical Study or Trial?
A clinical research study is also called a clinical trial. Each study tests the safety, effectiveness, and side effects of an investigational medicine(s) or an investigational device on a group of volunteers. Clinical research studies are an important step in making new investigational medications available for future use.
Go back to the top
Should I volunteer
Every day, research uncovers new information about diseases and their treatment. By taking part in a clinical research study, you are an important link in a long chain of research and testing of new investigational medicines for future use.
Go back to the top
Devoted to the advancement of pulmonary & COPD care.
At Midwest Chest Consultants, we are dedicated to providing the highest standard of care for patients with pulmonary disorders and diseases. For this reason, we’ve made a point of getting and staying involved in research studies that can improve the standard of care.
Today, in addition to our pulmonology practice, we run a full-time clinical trials operation. We have dedicated full-time professionals devoted to this part of our practice and to ensuring the most complete, thorough and accurate information and patient care. Since 1991, we have conducted nearly 70 different clinical trials, and we’re today in demand by pharmaceutical companies who demand top-quality investigative data. We are presently conducting several studies on COPD, and we have more planned for the future.
Go back to the top
How can patients benefit from participation in clinical trials?
With decades of experience as pulmonologists and investigators, we know that patients — particularly those with COPD — are interested in receiving closer care. In other words, they desire more hands-on time with the specialist, which is a key motivator for patients to participate in clinical trials. This is particularly the case for patients who are still struggling with their illness despite treatment.
Patients considering participation in COPD studies also benefit simply from the screening process. Regardless of whether they are chosen for the study, they receive a “snapshot” of their lung function (spirometry) at no cost. Other motivators include greater frequency of specialty tests and exams, zero-cost medications and care, priority visits, reimbursement for time and expenses and the potential for effective relief that has otherwise been elusive.
Go back to the top
Who is eligible?
Today, most pharmaceutical companies that are researching new treatments desire a particular type of COPD patient. For starters, because age is an important factor in the incidence of COPD, patients must be age 40 or older in order to be eligible. A personal history of smoking is also a key eligibility factor, and the ideal candidate is a COPD patient who has a history of one or more packs per day for 10 or more years.
If you or someone you know is interested in a COPD clinical trial, please call us for more information.
Go back to the top
COPD facts & stats:
- COPD is the fourth-leading cause of death in America.
- In 2004, 11.4 million U.S. adults were estimated to have COPD. However, close to 24 million adults have evidence of impaired lung function, indicating that COPD is underdiagnosed.
- Smoking is the primary risk factor for COPD. Approximately 80% to 90% of COPD cases are caused by smoking.
- Female smokers are nearly 13 times as likely to die from COPD as women who have never smoked. Male smokers are nearly 12 times as likely to die from COPD as men who have never smoked.
- The number of women dying from COPD is greater than the number of men.
- In 2004, an estimated 9 million Americans reported a physician diagnosis of chronic bronchitis. Chronic bronchitis affects people of all ages but is higher in those over 45 years old. Of the estimated 3.6 million Americans ever diagnosed with emphysema, 91% were 45 or older.
Source: American Lung Association
Go back to the top
|
| |
|